Cardio Diagnostics Holdings, Inc. (CDIOW) stock
CDIOWNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as CDIO
$0.01+0.00 (0.00%)
Close on Oct 30, 2026Market cap $4.94MP/E –Yield –
Cardio Diagnostics total assets
Total assets on the balance sheet at the end of each period.
Cardio Diagnostics's total assets was $7.93M at Jun 30, 2026. For fiscal 2025 it was $7.77M, down 26.8% from the year before. The highest annual figure on record is $10.62M in fiscal 2024.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.77M | -26.8% |
| FY2024 | Dec 31, 2024 | $10.62M | +137.9% |
| FY2023 | Dec 31, 2023 | $4.46M | -28.6% |
| FY2022 | Dec 31, 2022 | $6.25M | +467.1% |
| FY2021 | Dec 31, 2021 | $1.10M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $7.93M | -35.5% |
| Q1 FY2026 | Mar 31, 2026 | $9.56M | -9.9% |
| Q4 FY2025 | Dec 31, 2025 | $7.77M | +73.3% |
| Q3 FY2025 | Sep 30, 2025 | $8.79M | +119.9% |
| Q1 FY2025 | Mar 31, 2025 | $12.28M | +183.8% |
| Q4 FY2024 | Dec 31, 2024 | $10.62M | +137.9% |
| Q3 FY2024 | Sep 30, 2024 | $4.48M | -24.8% |
| Q2 FY2024 | Jun 30, 2024 | $4.00M | -40.8% |
| Q1 FY2024 | Mar 31, 2024 | $4.33M | -49.4% |
| Q4 FY2023 | Dec 31, 2023 | $4.46M | -28.6% |
| Q3 FY2023 | Sep 30, 2023 | $5.96M | -90.9% |
| Q2 FY2023 | Jun 30, 2023 | $6.76M | -89.7% |
| Q1 FY2023 | Mar 31, 2023 | $8.55M | +676.0% |
| Q4 FY2022 | Dec 31, 2022 | $6.25M | – |
| Q2 FY2022 | Jun 30, 2022 | $65.20M | – |
| Q1 FY2022 | Mar 31, 2022 | $65.64M | – |
| Q4 FY2021 | Dec 31, 2021 | $1.10M | – |